| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MAM.2012.10.010 |
| P698 | PubMed publication ID | 23506881 |
| P2093 | author name string | Hermann Koepsell | |
| P433 | issue | 2-3 | |
| P304 | page(s) | 413-435 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Molecular Aspects of Medicine | Q6895933 |
| P1476 | title | The SLC22 family with transporters of organic cations, anions and zwitterions | |
| P478 | volume | 34 |
| Q30827518 | A critical role of solute carrier 22a14 in sperm motility and male fertility in mice |
| Q28820987 | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
| Q42065254 | A primary fish gill cell culture model to assess pharmaceutical uptake and efflux: evidence for passive and facilitated transport. |
| Q38419627 | Absolute protein quantification allows differentiation of cell-specific metabolic routes and functions |
| Q90099257 | Advances and Challenges in Rational Drug Design for SLCs |
| Q40362672 | Bacillus cereus efflux protein BC3310 - a multidrug transporter of the unknown major facilitator family, UMF-2. |
| Q38265546 | Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2) and the N-terminal Domain of Its Endocytic Receptor SLC22A17. |
| Q35729830 | Carnitine Deficiency and Pregnancy. |
| Q38872245 | Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells. |
| Q28537671 | Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes |
| Q52680667 | Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter. |
| Q33584577 | Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake |
| Q93352854 | Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter |
| Q28546572 | Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines |
| Q100733503 | Comprehensive in-silico analysis of damage associated SNPs in hOCT1 affecting Imatinib response in chronic myeloid leukemia |
| Q38833698 | Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs. |
| Q41959197 | Cytosolic calcium measurements in renal epithelial cells by flow cytometry |
| Q30767215 | Drosophila SLC22A Transporter Is a Memory Suppressor Gene that Influences Cholinergic Neurotransmission to the Mushroom Bodies |
| Q27319910 | Drosophila Vision Depends on Carcinine Uptake by an Organic Cation Transporter |
| Q38342677 | Drug transporters in the central nervous system |
| Q38254730 | Effect of drug transporter pharmacogenetics on cholestasis |
| Q38362582 | Efflux transporters in blood-brain interfaces of the developing brain |
| Q28552720 | Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells |
| Q92542129 | Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction |
| Q28550639 | Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs |
| Q41487826 | Exposure Characteristics of the Analogous β-Carboline Alkaloids Harmaline and Harmine Based on the Efflux Transporter of Multidrug Resistance Protein 2. |
| Q38859468 | Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation |
| Q38199198 | Extrahepatic metabolism at the body's internal-external interfaces. |
| Q36624084 | Folic acid reverses uric acid crystal-induced surface OAT1 internalization by inhibiting RhoA activity in uric acid nephropathy |
| Q47873443 | From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century |
| Q50083195 | GeneGini: Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and Diverse Human Transporter Expression Profiles. |
| Q55514622 | Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition. |
| Q38852147 | Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans. |
| Q90448277 | Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol |
| Q63352451 | Genome-wide association meta-analysis for total thyroid hormone levels in Croatian population |
| Q36045132 | Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes |
| Q34489702 | Glutamate cycling may drive organic anion transport on the basal membrane of human placental syncytiotrophoblast. |
| Q53669241 | Glutathione is a low-affinity substrate of the human sodium-dependent dicarboxylate transporter. |
| Q37001887 | Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway |
| Q36250282 | Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters |
| Q39204754 | Harnessing Solute Carrier Transporters for Precision Oncology |
| Q48493977 | Histamine Clearance Through Polyspecific Transporters in the Brain. |
| Q38738684 | Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT/SLC29A4). |
| Q53817407 | Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function. |
| Q38888369 | Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant? |
| Q48150663 | Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling |
| Q47808595 | Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype. |
| Q38202698 | Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions |
| Q55030406 | Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma. |
| Q38773140 | Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine |
| Q38685365 | Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes |
| Q38833348 | Loops and layers of post-translational modifications of drug transporters |
| Q28597594 | MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites |
| Q26747796 | Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy |
| Q95795711 | Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach |
| Q44984652 | Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules |
| Q35979992 | Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2. |
| Q38878584 | Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation |
| Q35066350 | Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. |
| Q38114865 | OCTN cation transporters in health and disease: role as drug targets and assay development |
| Q48363596 | On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent. |
| Q37203854 | Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity |
| Q42705138 | Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin |
| Q34974830 | Organic cation transporter variation and response to smoking cessation therapies |
| Q91939446 | Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver |
| Q33671763 | PharmGKB summary: very important pharmacogene information for SLC22A1 |
| Q34542169 | Pharmacogenetic Optimization of Smoking Cessation Treatment |
| Q41845623 | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes. |
| Q38183877 | Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism |
| Q36103220 | Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio). |
| Q48704566 | Pinocembrin attenuates gentamicin-induced nephrotoxicity in rats. |
| Q38851414 | Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics |
| Q39098184 | Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids |
| Q38555255 | Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders |
| Q56985288 | Prioritization of Transporter-Drug Relationships From Drug Sensitivity Screens |
| Q64253121 | RNA-Seq Transcriptome Profiling of the Queen Scallop (Aequipecten opercularis) Digestive Gland after Exposure to Domoic Acid-Producing Pseudo-nitzschia |
| Q35108977 | Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats |
| Q92153121 | Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion |
| Q39140289 | Renal Drug Transporters and Drug Interactions |
| Q28071292 | Renal drug transporters and their significance in drug-drug interactions |
| Q92626498 | Role of OCT1 in hepatocellular carcinoma |
| Q38622785 | Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions. |
| Q47130749 | Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma |
| Q38553282 | Role of organic cation transporters in drug-drug interaction |
| Q27027625 | Role of solute carriers in response to anticancer drugs |
| Q27026858 | Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology |
| Q39406418 | SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers |
| Q92330328 | Salinity stress-induced differentially expressed miRNAs and target genes in sea cucumbers Apostichopus japonicus |
| Q38269878 | Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target |
| Q93016064 | Solute carrier transporters: the metabolic gatekeepers of immune cells |
| Q34253116 | Structural insights into the transport of small molecules across membranes |
| Q30486743 | The Concise Guide to PHARMACOLOGY 2013/14: transporters |
| Q33809605 | The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers |
| Q26799364 | The Regulation of Steroid Action by Sulfation and Desulfation |
| Q26741190 | The Role of Cyclo(His-Pro) in Neurodegeneration |
| Q38888345 | The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations |
| Q89684787 | The biology of ergothioneine, an antioxidant nutraceutical |
| Q36539745 | The carcinine transporter CarT is required in Drosophila photoreceptor neurons to sustain histamine recycling. |
| Q64121686 | The glial sodium-potassium-2-chloride cotransporter is required for synaptic transmission in the Drosophila visual system |
| Q36564944 | The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin |
| Q38642449 | The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation. |
| Q40364919 | The in vivo disposition and in vitro transmembrane transport of two model radiometabolites of DOTA-conjugated receptor-specific peptides labelled with (177) Lu. |
| Q57153113 | The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions |
| Q28085671 | The organic anion transporter (OAT) family: a systems biology perspective |
| Q35563701 | The physiological role of drug transporters |
| Q38962943 | The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family |
| Q49824379 | The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes. |
| Q41383925 | The β-alanine transporter BalaT is required for visual neurotransmission in Drosophila. |
| Q34737607 | Thermodynamic evidence for a dual transport mechanism in a POT peptide transporter |
| Q39181492 | Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease. |
| Q48592023 | Transporters involved in renal excretion of N-carbamoylglutamate, an orphan drug to treat inborn n-acetylglutamate synthase deficiency. |
| Q53211992 | Understanding transport by the major facilitator superfamily (MFS): structures pave the way. |
| Q90280032 | Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies |
| Q36235662 | Uremic Solutes in Chronic Kidney Disease and Their Role in Progression |
| Q41617023 | Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently |
| Q60975818 | Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors |
| Q36571217 | What do drug transporters really do? |
| Q36817792 | Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter |
| Q54987110 | Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters. |
Search more.